These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Kava consumption and its health effects. Gounder R Pac Health Dialog; 2006 Sep; 13(2):131-5. PubMed ID: 18181402 [TBL] [Abstract][Full Text] [Related]
28. Adverse reactions to dietary supplements under investigation by FDA. Marwick C BMJ; 2002 Aug; 325(7359):298. PubMed ID: 12173613 [No Abstract] [Full Text] [Related]
29. Safety concerns about kava. Ernst E Lancet; 2002 May; 359(9320):1865. PubMed ID: 12044412 [No Abstract] [Full Text] [Related]
30. FDA issues alert on ephedra supplements in the USA. Nelson R Lancet; 2004 Jan; 363(9403):135. PubMed ID: 14733193 [No Abstract] [Full Text] [Related]
31. FDA faces barrage of criticism over plans to assess safety of supplements. Epstein K BMJ; 2012 Jan; 344():e583. PubMed ID: 22277134 [No Abstract] [Full Text] [Related]
32. Dietary supplements and lessons to be learned from GRAS. Burdock GA Regul Toxicol Pharmacol; 2000 Feb; 31(1):68-76. PubMed ID: 10715226 [TBL] [Abstract][Full Text] [Related]
33. Teratology society: presentation to the FDA public meeting on safety issues associated with the use of dietary supplements during pregnancy. Friedman JM Teratology; 2000 Aug; 62(2):134-7. PubMed ID: 10931511 [No Abstract] [Full Text] [Related]
34. FDA regulation of dietary supplements and requirements regarding adverse event reporting. Frankos VH; Street DA; O'Neill RK Clin Pharmacol Ther; 2010 Feb; 87(2):239-44. PubMed ID: 20032973 [TBL] [Abstract][Full Text] [Related]
35. Botanical supplements: weeding out the health risks. Taylor DA Environ Health Perspect; 2004 Sep; 112(13):A750-3. PubMed ID: 15345365 [No Abstract] [Full Text] [Related]
36. United States pharmacopeia safety evaluation of spirulina. Marles RJ; Barrett ML; Barnes J; Chavez ML; Gardiner P; Ko R; Mahady GB; Low Dog T; Sarma ND; Giancaspro GI; Sharaf M; Griffiths J Crit Rev Food Sci Nutr; 2011 Aug; 51(7):593-604. PubMed ID: 21793723 [TBL] [Abstract][Full Text] [Related]
37. Regulatory and ethical issues with dietary supplements. Harris IM Pharmacotherapy; 2000 Nov; 20(11):1295-302. PubMed ID: 11079277 [TBL] [Abstract][Full Text] [Related]
38. An FDA guide to dietary supplements. Kurtzweil P FDA Consum; 1998; 32(5):28-35. PubMed ID: 9779010 [No Abstract] [Full Text] [Related]
40. Dietary Supplements: How Family Physicians Can Address Safety Concerns by Working with the FDA. Marks NS Am Fam Physician; 2016 Jan; 93(2):97-8. PubMed ID: 26926404 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]